Home Cart 0 Sign in  

[ CAS No. 30169-25-6 ] {[proInfo.proName]}

,{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]}
HazMat Fee +

There will be a HazMat fee per item when shipping a dangerous goods. The HazMat fee will be charged to your UPS/DHL/FedEx collect account or added to the invoice unless the package is shipped via Ground service. Ship by air in Excepted Quantity (each bottle), which is up to 1g/1mL for class 6.1 packing group I or II, and up to 25g/25ml for all other HazMat items.

Type HazMat fee for 500 gram (Estimated)
Excepted Quantity USD 0.00
Limited Quantity USD 15-60
Inaccessible (Haz class 6.1), Domestic USD 80+
Inaccessible (Haz class 6.1), International USD 150+
Accessible (Haz class 3, 4, 5 or 8), Domestic USD 100+
Accessible (Haz class 3, 4, 5 or 8), International USD 200+
Chemical Structure| 30169-25-6
Chemical Structure| 30169-25-6
Structure of 30169-25-6 * Storage: {[proInfo.prStorage]}
Cart0 Add to My Favorites Add to My Favorites Bulk Inquiry Inquiry Add To Cart

Quality Control of [ 30169-25-6 ]

Related Doc. of [ 30169-25-6 ]

Alternatived Products of [ 30169-25-6 ]

Product Details of [ 30169-25-6 ]

CAS No. :30169-25-6 MDL No. :MFCD00173232
Formula : C12H14N8 Boiling Point : -
Linear Structure Formula :- InChI Key :FPKOARNUITZHCF-UHFFFAOYSA-N
M.W : 270.29 Pubchem ID :577984
Synonyms :

Calculated chemistry of [ 30169-25-6 ]

Physicochemical Properties

Num. heavy atoms : 20
Num. arom. heavy atoms : 16
Fraction Csp3 : 0.33
Num. rotatable bonds : 2
Num. H-bond acceptors : 6.0
Num. H-bond donors : 0.0
Molar Refractivity : 71.73
TPSA : 87.2 Ų

Pharmacokinetics

GI absorption : High
BBB permeant : No
P-gp substrate : No
CYP1A2 inhibitor : No
CYP2C19 inhibitor : Yes
CYP2C9 inhibitor : No
CYP2D6 inhibitor : No
CYP3A4 inhibitor : No
Log Kp (skin permeation) : -7.37 cm/s

Lipophilicity

Log Po/w (iLOGP) : 2.77
Log Po/w (XLOGP3) : 0.82
Log Po/w (WLOGP) : 0.87
Log Po/w (MLOGP) : 2.31
Log Po/w (SILICOS-IT) : 0.77
Consensus Log Po/w : 1.51

Druglikeness

Lipinski : 0.0
Ghose : None
Veber : 0.0
Egan : 0.0
Muegge : 0.0
Bioavailability Score : 0.55

Water Solubility

Log S (ESOL) : -2.49
Solubility : 0.87 mg/ml ; 0.00322 mol/l
Class : Soluble
Log S (Ali) : -2.23
Solubility : 1.58 mg/ml ; 0.00584 mol/l
Class : Soluble
Log S (SILICOS-IT) : -3.52
Solubility : 0.0822 mg/ml ; 0.000304 mol/l
Class : Soluble

Medicinal Chemistry

PAINS : 0.0 alert
Brenk : 0.0 alert
Leadlikeness : 0.0
Synthetic accessibility : 2.78

Safety of [ 30169-25-6 ]

Signal Word:Danger Class:4.1
Precautionary Statements:P240-P210-P241-P264-P280-P302+P352-P370+P378-P337+P313-P305+P351+P338-P362+P364-P332+P313 UN#:1325
Hazard Statements:H315-H319-H228 Packing Group:
GHS Pictogram:

Application In Synthesis of [ 30169-25-6 ]

* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.

  • Upstream synthesis route of [ 30169-25-6 ]
  • Downstream synthetic route of [ 30169-25-6 ]

[ 30169-25-6 ] Synthesis Path-Upstream   1~5

  • 1
  • [ 30169-25-6 ]
  • [ 3398-16-1 ]
Reference: [1] Russian Journal of Organic Chemistry, 1999, vol. 35, # 9, p. 1363 - 1371
  • 2
  • [ 30169-21-2 ]
  • [ 30169-25-6 ]
YieldReaction ConditionsOperation in experiment
91% With acetic acid; sodium nitrite In dichloromethane; water at 0℃; Dissolve 26.2 g of sodium nitrite in 588 ml of water, 60 ml of dichloromethane are added, Cooled to 0 ° C, Then (37 g, 0.136 mol) of compound 2 was added, Acetic acid (18.67 ml, 0.326 mol) was added dropwise. When gas evolution ceased, methylene chloride was extracted and the organic phase was washed with potassium carbonate solution, After drying over magnesium sulfate, the organic solvent was spun off and recrystallized from ether to give compound 3 (33.45 g, 91percent).
Reference: [1] Journal of Heterocyclic Chemistry, 1991, vol. 28, # 8, p. 2049 - 2050
[2] Chemical Communications, 2013, vol. 49, # 87, p. 10275 - 10277
[3] Dalton Transactions, 2017, vol. 46, # 8, p. 2471 - 2478
[4] Journal of Chemical Crystallography, 2012, vol. 42, # 6, p. 600 - 605
[5] European Journal of Organic Chemistry, 2009, # 35, p. 6121 - 6128
[6] Patent: CN107286186, 2017, A, . Location in patent: Paragraph 0024; 0058-0061
[7] Journal of Fluorine Chemistry, 2009, vol. 130, # 4, p. 377 - 382
[8] Journal of Physical Organic Chemistry, 2014, vol. 27, # 8, p. 670 - 675
[9] Journal of Coordination Chemistry, 2017, vol. 70, # 14, p. 2384 - 2392
[10] Zeitschrift fur Anorganische und Allgemeine Chemie, 2018, vol. 644, # 11, p. 512 - 517
  • 3
  • [ 30169-21-2 ]
  • [ 30169-25-6 ]
Reference: [1] Chemical Communications, 2013, vol. 49, # 92, p. 10808 - 10810
[2] Bioorganic and Medicinal Chemistry Letters, 2010, vol. 20, # 15, p. 4496 - 4498
  • 4
  • [ 123-54-6 ]
  • [ 30169-25-6 ]
Reference: [1] Chemical Communications, 2013, vol. 49, # 92, p. 10808 - 10810
  • 5
  • [ 30169-25-6 ]
  • [ 106131-61-7 ]
Reference: [1] Journal of Physical Organic Chemistry, 2014, vol. 27, # 8, p. 670 - 675
Same Skeleton Products
Historical Records

Related Parent Nucleus of
[ 30169-25-6 ]

Pyrazoles

Chemical Structure| 1072-91-9

[ 1072-91-9 ]

1,3,5-Trimethylpyrazole

Similarity: 0.58

Chemical Structure| 1017781-37-1

[ 1017781-37-1 ]

3-Ethyl-1-phenyl-1H-pyrazol-5-amine

Similarity: 0.56

Chemical Structure| 4023-02-3

[ 4023-02-3 ]

1H-Pyrazole-1-carboximidamide hydrochloride

Similarity: 0.55

Chemical Structure| 423768-52-9

[ 423768-52-9 ]

3-(Aminomethyl)-1,5-dimethylpyrazole

Similarity: 0.55

Chemical Structure| 28466-21-9

[ 28466-21-9 ]

1,3,5-Trimethyl-1H-pyrazol-4-amine

Similarity: 0.55